المؤلفون: Vicente E., Mumbach M.R., Granja J., Beretta L., Simeon C.P., Carreira P., Ortego-Centeno N., Castellvi I., Bossini-Castillo L., Carmona F.D., Orozco G., Hunzelmann N., Distler J.H.W., Franke A., Lunardi C., Moroncini G., Gabrielli A., de Vries-Bouwstra J., Wijmenga C., Koeleman B.P.C., Nordin A., Padyukov L., Hoffmann-Vold A.-M., Lie B., Rios R., Callejas J.L., Vargas-Hitos J.A., Garcia-Portales R., Camps M.T., Fernandez-Nebro A., Gonzalez-Escribano M.F., Garcia-Hernandez F.J., Castillo M.J., Aguirre M.A., Gomez-Gracia I., Fernandez-Gutierrez B., Rodriguez-Rodriguez L., Garcia de la Pena P., Andreu J.L., Fernandez de Castro M., Lopez-Longo F.J., Martinez L., Fonollosa, Guillen A., Espinosa G., Tolosa C., Pros A., Rodriguez-Carballeira M., Narvaez F.J., Rubio-Rivas M., Ortiz-Santamaria, Madronero A.B., Gonzalez-Gay M.A., Diaz B., Trapiella L., Sousa A., Egurbide M.V., Fanlo-Mateo P., Saez-Comet L., Diaz F., Hernandez, Beltran E., Roman-Ivorra J.A., Grau E., Alegre-Sancho J.J., Freire M., Blanco-Garcia F.J., Oreiro N., Witte T., Kreuter A., Riemekasten G., Airo P., Magro C., Voskuyl A.E., Vonk M.C., Hesselstrand R., Proudman S., Stevens W., Nikpour M., Zochling J., Sahhar J., Roddy J., Nash P., Tymms K., Rischmueller M., Lester S., Vyse T., Herrick A.L., Worthington J., Denton C.P., Allanore Y., Brown M.A., Radstake T.R.D.J., Fonseca C., Chang H.Y., Mayes M.D., Martin J., Lopez-Isac E., Acosta-Herrera M., Kerick M., Assassi S., Satpathy A.T.

مصطلحات الفهرس: article, genome-wide association study, human, immune response, major clinical study, molecular genetics, protein acetylation, rheumatic disease, risk factor, single nucleotide polymorphism, systemic sclerosis, T lymphocyte, vascular disease, centromere antibody/ec [Endogenous Compound], interferon consensus sequence binding protein/ec [Endogenous Compound], STAT4 protein/ec [Endogenous Compound], transcription factor/ec [Endogenous Compound], unclassified drug, C terminal Src kinase/ec [Endogenous Compound], cluster of differentiation 247/ec [Endogenous Compound], complexin 3/ec [Endogenous Compound], diacylglycerol kinase theta/ec [Endogenous Compound], gasdermin a/ec [Endogenous Compound], histone 3 lysine 27/ec [Endogenous Compound], interleukin 12 receptor subunit beta 1/ec [Endogenous Compound], interleukin 12 receptor subunit beta 2/ec [Endogenous Compound], lectin, mannose binding 1 like/ec [Endogenous Compound], mitochondrial ribosomal protein S7/ec [Endogenous Compound], nucleoporin 85/ec [Endogenous Compound], ORMDL sphingolipid biosynthesis regulator 3/ec [Endogenous Compound], phosphopantothenoylcysteine decarboxylase/ec [Endogenous Compound], post GPI attachment to proteins 3/ec [Endogenous Compound], proteasome 26S subunit, non-ATPase 3/ec [Endogenous Compound], Rho GTPase activating protein 31/ec [Endogenous Compound], ribonuclease P and MRP subunit p25/ec [Endogenous Compound], TNFAIP3 interacting protein 1/ec [Endogenous Compound], zona pellucida binding protein 2/ec [Endogenous Compound], Bayesian network, CD4+ T lymphocyte, cell expansion, cohort analysis, controlled study, epigenetics, fibrosis, gene identification, gene locus, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35863
Nature Communications
Click here for full text options
LibKey Link

المؤلفون: Vicente E., Mumbach M.R., Granja J., Beretta L., Simeon C.P., Carreira P., Ortego-Centeno N., Castellvi I., Bossini-Castillo L., Carmona F.D., Orozco G., Hunzelmann N., Distler J.H.W., Franke A., Lunardi C., Moroncini G., Gabrielli A., de Vries-Bouwstra J., Wijmenga C., Koeleman B.P.C., Nordin A., Padyukov L., Hoffmann-Vold A.-M., Lie B., Rios R., Callejas J.L., Vargas-Hitos J.A., Garcia-Portales R., Camps M.T., Fernandez-Nebro A., Gonzalez-Escribano M.F., Garcia-Hernandez F.J., Castillo M.J., Aguirre M.A., Gomez-Gracia I., Fernandez-Gutierrez B., Rodriguez-Rodriguez L., Garcia de la Pena P., Andreu J.L., Fernandez de Castro M., Lopez-Longo F.J., Martinez L., Fonollosa, Guillen A., Espinosa G., Tolosa C., Pros A., Rodriguez-Carballeira M., Narvaez F.J., Rubio-Rivas M., Ortiz-Santamaria, Madronero A.B., Gonzalez-Gay M.A., Diaz B., Trapiella L., Sousa A., Egurbide M.V., Fanlo-Mateo P., Saez-Comet L., Diaz F., Hernandez, Beltran E., Roman-Ivorra J.A., Grau E., Alegre-Sancho J.J., Freire M., Blanco-Garcia F.J., Oreiro N., Witte T., Kreuter A., Riemekasten G., Airo P., Magro C., Voskuyl A.E., Vonk M.C., Hesselstrand R., Proudman S., Stevens W., Nikpour M., Zochling J., Sahhar J., Roddy J., Nash P., Tymms K., Rischmueller M., Lester S., Vyse T., Herrick A.L., Worthington J., Denton C.P., Allanore Y., Brown M.A., Radstake T.R.D.J., Fonseca C., Chang H.Y., Mayes M.D., Martin J., Lopez-Isac E., Acosta-Herrera M., Kerick M., Assassi S., Satpathy A.T.

مصطلحات الفهرس: article, genome-wide association study, human, immune response, major clinical study, molecular genetics, protein acetylation, rheumatic disease, risk factor, single nucleotide polymorphism, systemic sclerosis, T lymphocyte, vascular disease, centromere antibody/ec [Endogenous Compound], interferon consensus sequence binding protein/ec [Endogenous Compound], STAT4 protein/ec [Endogenous Compound], transcription factor/ec [Endogenous Compound], unclassified drug, C terminal Src kinase/ec [Endogenous Compound], cluster of differentiation 247/ec [Endogenous Compound], complexin 3/ec [Endogenous Compound], diacylglycerol kinase theta/ec [Endogenous Compound], gasdermin a/ec [Endogenous Compound], histone 3 lysine 27/ec [Endogenous Compound], interleukin 12 receptor subunit beta 1/ec [Endogenous Compound], interleukin 12 receptor subunit beta 2/ec [Endogenous Compound], lectin, mannose binding 1 like/ec [Endogenous Compound], mitochondrial ribosomal protein S7/ec [Endogenous Compound], nucleoporin 85/ec [Endogenous Compound], ORMDL sphingolipid biosynthesis regulator 3/ec [Endogenous Compound], phosphopantothenoylcysteine decarboxylase/ec [Endogenous Compound], post GPI attachment to proteins 3/ec [Endogenous Compound], proteasome 26S subunit, non-ATPase 3/ec [Endogenous Compound], Rho GTPase activating protein 31/ec [Endogenous Compound], ribonuclease P and MRP subunit p25/ec [Endogenous Compound], TNFAIP3 interacting protein 1/ec [Endogenous Compound], zona pellucida binding protein 2/ec [Endogenous Compound], Bayesian network, CD4+ T lymphocyte, cell expansion, cohort analysis, controlled study, epigenetics, fibrosis, gene identification, gene locus, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35863
Nature Communications
LibKey Link

المؤلفون: Low M., Tarlinton D., Grigoriadis G., Infantino S.

مصطلحات الفهرس: immunostimulation, kidney transplantation, liver transplantation, lung transplantation, memory cell, myeloma, phase 2 clinical trial (topic), phase 3 clinical trial (topic), plasma cell, priority journal, randomized controlled trial (topic), review, target cell, B lymphocyte induced maturation protein 1/ec [Endogenous Compound], cell surface marker/ec [Endogenous Compound], corticosteroid, daratumumab, dexamethasone, indatuximab ravtansine, interferon consensus sequence binding protein/ec [Endogenous Compound], interferon regulatory factor 4/ec [Endogenous Compound], lenalidomide, pomalidomide, proteasome inhibitor, protein bcl 6/ec [Endogenous Compound], protein mcl 1/ec [Endogenous Compound], siltuximab, thalidomide, transcription factor PAX5/ec [Endogenous Compound], X box binding protein 1/ec [Endogenous Compound], plasmacytoma, adaptive immunity, antibody mediated rejection, antibody production, antibody secreting cell, autoimmune disease, B lymphocyte, cell differentiation, cell fate, cell maturation, clinical effectiveness, clinical trial (topic), cytology, drug targeting, epigenetics, heart transplantation, human, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39904
Immunological Reviews
Click here for full text options
LibKey Link

المؤلفون: Low M., Tarlinton D., Grigoriadis G., Infantino S.

مصطلحات الفهرس: immunostimulation, kidney transplantation, liver transplantation, lung transplantation, memory cell, myeloma, phase 2 clinical trial (topic), phase 3 clinical trial (topic), plasma cell, priority journal, randomized controlled trial (topic), review, target cell, B lymphocyte induced maturation protein 1/ec [Endogenous Compound], cell surface marker/ec [Endogenous Compound], corticosteroid, daratumumab, dexamethasone, indatuximab ravtansine, interferon consensus sequence binding protein/ec [Endogenous Compound], interferon regulatory factor 4/ec [Endogenous Compound], lenalidomide, pomalidomide, proteasome inhibitor, protein bcl 6/ec [Endogenous Compound], protein mcl 1/ec [Endogenous Compound], siltuximab, thalidomide, transcription factor PAX5/ec [Endogenous Compound], X box binding protein 1/ec [Endogenous Compound], plasmacytoma, adaptive immunity, antibody mediated rejection, antibody production, antibody secreting cell, autoimmune disease, B lymphocyte, cell differentiation, cell fate, cell maturation, clinical effectiveness, clinical trial (topic), cytology, drug targeting, epigenetics, heart transplantation, human, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39904
Immunological Reviews
LibKey Link